V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010140 | 280008836 | 1.7 | 91.9 | Palliative (P) | 2015-11-26 | 2015-12-20 | Paclitaxel 7 day | 02 | N | 280026530 | PACLITAXEL |
| 280010141 | 280005388 | 1.52 | 44.8 | Neo-adjuvant (N) | 2017-03-12 | 2017-03-13 | IVA | 02 | null | 280026547 | IVA |
| 280010142 | 280011307 | 1.73 | 89.4 | Palliative (P) | null | 2017-04-08 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026571 | IVA |
| 280010143 | 280011307 | 1.68 | 78.9 | Neo-adjuvant (N) | 2017-08-20 | 2017-08-21 | Doxorubicin 75mg/m2 | 02 | null | 280026571 | DOXORUBICIN |
| 280010144 | 280011307 | 0.84 | 95 | Curative (C) | 2015-12-09 | 2015-12-22 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | Y | 280026571 | RMS 2005 TRIAL |
| 280010145 | 280011307 | 0 | null | Palliative (P) | 2017-10-26 | 2017-10-30 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280026571 | RMS 2005 TRIAL |
| 280010146 | 280005392 | null | 91 | Palliative (P) | 2018-01-16 | 2018-02-15 | Cisplatin 7 day | null | Y | 280026606 | CISPLATIN |
| 280010147 | 280011308 | 1.57 | null | null | 2014-06-24 | 2014-08-06 | Cisplatin | 02 | N | 280026607 | CISPLATIN |
| 280010148 | 280005393 | 1.85 | 92 | Palliative (P) | 2016-05-02 | 2016-05-23 | Cetuximab + Radiotherapy Maint | 01 | N | 280026608 | CETUXIMAB + RT |
| 280010149 | 280005397 | 1.29 | 86 | Palliative (P) | null | 2015-12-12 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | N | 280026624 | IVA |
| 280010150 | 280005401 | 1.88 | 57.3 | Adjuvant (A) | 2017-12-20 | 2018-02-11 | CARBOPLATIN + RT | N | Y | 280026663 | CARBOPLATIN + RT |
| 280010151 | 280008846 | 0 | null | Palliative (P) | 2014-12-12 | 2015-02-28 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280026670 | RMS 2005 TRIAL |
| 280010152 | 280005403 | 1.68 | 88 | Palliative (P) | 2016-10-30 | 2017-02-07 | Doxorubicin 75mg/m2 | N | N | 280026673 | DOXORUBICIN |
| 280010153 | 280005405 | 0.9 | 60.5 | Palliative (P) | 2014-09-04 | 2014-09-18 | Cetuximab + Radiotherapy Maint | 01 | N | 280026688 | CETUXIMAB + RT |
| 280010154 | 280005406 | 1.55 | 70.6 | Palliative (P) | 2015-09-18 | 2015-10-09 | CETUXIMAB + RT | 02 | null | 280026689 | CETUXIMAB + RT |
| 280010155 | 280008849 | null | 40.8 | Palliative (P) | 2014-08-31 | 2014-10-09 | CETUXIMAB + RT | N | N | 280026692 | CETUXIMAB + RT |
| 280010156 | 280008849 | 1.73 | 90.9 | null | 2013-02-22 | 2013-07-26 | Ifosfamide | N | N | 280026692 | IFOSFAMIDE |
| 280010157 | 280005407 | 0 | 40.8 | Neo-adjuvant (N) | 2015-03-19 | 2015-09-10 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | 280026700 | RMS 2005 TRIAL |
| 280010158 | 280008851 | 1.7 | null | Curative (C) | 2013-11-13 | 2014-04-24 | CETUXIMAB + RT | N | N | 280026704 | CETUXIMAB + RT |
| 280010159 | 280008853 | 1.65 | 53.4 | Palliative (P) | 2016-10-25 | 2016-11-21 | Ifosfamide | N | N | 280026704 | IFOSFAMIDE |
| 280010160 | 280008853 | 1.7 | 65.55 | null | 2015-10-20 | 2017-02-28 | DOXORUBICIN | N | N | 280026704 | DOXORUBICIN |
| 280010161 | 280005417 | 0.99 | 81 | Neo-adjuvant (N) | 2017-08-12 | 2017-08-19 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280026722 | IVA |
| 280010162 | 280008854 | 1.49 | 70.6 | Palliative (P) | 2015-06-16 | 2015-06-16 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 280026724 | PACLITAXEL |
| 280010163 | 280005425 | 0 | 78 | Disease modification (D) | 2015-11-21 | 2015-11-24 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280026741 | RMS 2005 TRIAL |
| 280010164 | 280005426 | 1.63 | 25.5 | Curative (C) | 2013-07-20 | 2013-08-02 | Cisplatin | N | Y | 280026744 | CISPLATIN |
| 280010165 | 280008857 | 1.58 | 54.7 | Palliative (P) | 2017-05-07 | 2017-07-04 | Cetuximab + Radiotherapy Maint | N | Y | 280026746 | CETUXIMAB + RT |
| 280010166 | 280005428 | 1.74 | null | Palliative (P) | 2018-08-16 | 2018-08-26 | Ifosfamide | null | null | 280026758 | IFOSFAMIDE |
| 280010167 | 280005433 | 1.67 | 41.75 | Neo-adjuvant (N) | 2015-01-12 | 2015-01-19 | Ifosfamide 3g/m2 5 day | N | N | 280026793 | IFOSFAMIDE |
| 280010168 | 280008860 | 1.76 | 64.9 | Palliative (P) | 2018-02-03 | 2018-02-24 | DOXORUBICIN | null | null | 280026794 | DOXORUBICIN |
| 280010169 | 280005436 | 1.8 | 93.8 | Palliative (P) | 2014-08-26 | 2014-09-19 | Cisplatin 7 day | 02 | Y | 280026803 | CISPLATIN |
| 280010170 | 280010512 | null | 79.7 | Palliative (P) | 2014-10-15 | 2015-01-09 | IVA | N | N | 280026807 | IVA |
| 280010171 | 280005444 | 1.81 | null | Curative (C) | null | 2018-10-24 | Cetuximab + Radiotherapy Maint | 02 | N | 280026812 | CETUXIMAB + RT |
| 280010172 | 280010513 | 1.81 | 122 | Palliative (P) | 2015-09-24 | 2015-09-24 | PACLITAXEL | 02 | N | 280026817 | PACLITAXEL |
| 280010173 | 280005445 | 0 | 72.7 | Palliative (P) | 2015-09-05 | 2016-03-16 | STS Rhabdomyosarcoma RMS 2005 IVADo | Y | N | 280026818 | RMS 2005 TRIAL |
| 280010174 | 280005447 | 1.7 | 72.7 | Palliative (P) | 2015-12-21 | 2015-12-28 | Cetuximab + Radiotherapy Maint | N | N | 280026819 | CETUXIMAB + RT |
| 280010175 | 280005449 | 1.77 | 103 | Curative (C) | 2016-11-28 | 2017-01-20 | CETUXIMAB + RT | null | N | 280026821 | CETUXIMAB + RT |
| 280010176 | 280005450 | 1.68 | 14.8 | Palliative (P) | 2014-03-15 | 2014-03-20 | Ifosfamide | 02 | N | 280026824 | IFOSFAMIDE |
| 280010177 | 280005450 | 0.7 | 83 | Adjuvant (A) | 2013-07-07 | 2013-08-03 | CETUXIMAB + RT | N | null | 280026824 | CETUXIMAB + RT |
| 280010178 | 280008869 | 1.93 | 78.9 | Curative (C) | null | 2013-06-04 | Cisplatin | N | N | 280026839 | CISPLATIN |
| 280010179 | 280011318 | 1.59 | 87.6 | Adjuvant (A) | 2016-07-28 | 2016-08-04 | CARBOPLATIN + RT | Y | Y | 280026850 | CARBOPLATIN + RT |
| 280010180 | 280011712 | 1.88 | 74 | null | 2014-05-15 | 2015-12-16 | Ifosfamide | N | N | 280026861 | IFOSFAMIDE |
| 280010181 | 280005454 | 1.7 | null | Neo-adjuvant (N) | 2015-11-11 | 2015-12-09 | Cetuximab + Radiotherapy Maint | 2 | N | 280026865 | CETUXIMAB + RT |
| 280010182 | 280011319 | 0 | 98 | Palliative (P) | 2017-11-16 | 2017-11-20 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280026874 | RMS 2005 TRIAL |
| 280010183 | 280005457 | 1.6 | 48.8 | null | 2017-07-01 | 2017-07-01 | IVA | N | null | 280026890 | IVA |
| 280010184 | 280005459 | 1.85 | 73 | Palliative (P) | 2015-08-12 | 2015-08-28 | Cisplatin | N | Y | 280026892 | CISPLATIN |
| 280010185 | 280005461 | 1.8 | 85.3 | Palliative (P) | 2014-10-12 | 2014-10-12 | DOXORUBICIN | 02 | N | 280026893 | DOXORUBICIN |
| 280010186 | 280005462 | 1.85 | 97.2 | Palliative (P) | 2013-08-28 | 2013-09-11 | DOXORUBICIN | N | N | 280026898 | DOXORUBICIN |
| 280010187 | 280005463 | 1.52 | 75 | Curative (C) | 2014-12-18 | 2014-12-29 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280026900 | IVA |
| 280010188 | 280005467 | 1.7 | 16.8 | Palliative (P) | 2014-05-09 | 2014-05-16 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 280026902 | PACLITAXEL |
| 280010189 | 280005469 | 1.67 | 50.8 | Adjuvant (A) | 2017-08-15 | 2017-10-22 | CARBOPLATIN + RT | Y | N | 280026903 | CARBOPLATIN + RT |